ALFA Filings
Every announcement, straight from the exchange
Every Pfizer board meeting date announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Pfizer Limited has scheduled a board meeting for 3 November 2026 to consider unaudited standalone half-yearly results for the period ended September 2026. The trading window closes from 30 September 2026 until 5 November 2026.
Pfizer Limited has scheduled a board meeting for July 28, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 2026.
Pfizer Limited has scheduled a Board Meeting for May 12, 2026, to consider and approve financial results for the quarter and year ended March 31, 2026. The board will also consider a dividend recommendation. The company's trading window remains closed until May 14, 2026.
Pfizer Limited has scheduled a board meeting for May 12, 2026. The board will consider and approve audited standalone financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 14, 2026.
Pfizer Limited has scheduled a board meeting on May 12, 2026, to consider and approve audited standalone financial results for the year ended March 31, 2026. The board will also recommend a final dividend for the financial year 2025-26. The trading window remains closed until May 14, 2026.